Javascript must be enabled to continue!
Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
View through CrossRef
AbstractMycobacterium tuberculosis complex has an impact on public health and is responsible for over one million deaths per year. Substantial numbers of people infected with M. tuberculosis can develop tuberculosis lymphadenitis; however, there is a limited study in Adama, Ethiopia. The aim of this study was to determine the magnitude of Tuberculosis lymphadenitis, its predictors, and rifampicin-resistance gene-positive M. tuberculosis. A total of 291 patients with enlarged lymph nodes were recruited from May 2022 to August 30 at Adama Comprehensive Specialized Hospital Medical College (ACSHMC). GeneXpert, Ziehl–Neelsen staining, and cytology were used for the diagnosis of TB lymphadenitis from the Fine Needle Aspirate (FNA) specimen. Rifampicin-resistant gene was detected using GeneXpert. For data entry and analysis, Epi Data version 3.0 and SPSS version 25 were used respectively. A binary logistic regression model was used to identify predictors of TB lymphadenitis. A p < 0.05 with a 95% confidence interval (CI) was taken as a cut point to determine the significant association between dependent and independent variables. The prevalence of TB lymphadenitis using GeneXpert, Ziehl–Neelsen staining, and cytology were 138 (47.4%) (95% CI 41.70–53.10), 100 (34.4%) (95% CI 28.94–39.85), and 123 (42.3%) (95% CI 36.63–47.00) respectively. Nine (3.1%) participants were infected with rifampicin-resistant gene-positive M. tuberculosis. Out of the total M. tuberculosis detected by GeneXpert (n = 138), 9 (6.5%) were positive for rifampicin resistance-gene. Participants with a chronic cough had 2 times odds of developing TB lymphadenitis (AOR: 2.001, 95% CI 1.142–3.508). Close to half of patients with enlarged lymph nodes were positive for M. tuberculosis by the GeneXpert method in the study area. Chronic cough was significantly associated with TB lymphadenitis. Rifampicin-resistant gene-positive M. tuberculosis was relatively prevalent among patients with enlarged lymph node in the study area.
Springer Science and Business Media LLC
Title: Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
Description:
AbstractMycobacterium tuberculosis complex has an impact on public health and is responsible for over one million deaths per year.
Substantial numbers of people infected with M.
tuberculosis can develop tuberculosis lymphadenitis; however, there is a limited study in Adama, Ethiopia.
The aim of this study was to determine the magnitude of Tuberculosis lymphadenitis, its predictors, and rifampicin-resistance gene-positive M.
tuberculosis.
A total of 291 patients with enlarged lymph nodes were recruited from May 2022 to August 30 at Adama Comprehensive Specialized Hospital Medical College (ACSHMC).
GeneXpert, Ziehl–Neelsen staining, and cytology were used for the diagnosis of TB lymphadenitis from the Fine Needle Aspirate (FNA) specimen.
Rifampicin-resistant gene was detected using GeneXpert.
For data entry and analysis, Epi Data version 3.
0 and SPSS version 25 were used respectively.
A binary logistic regression model was used to identify predictors of TB lymphadenitis.
A p < 0.
05 with a 95% confidence interval (CI) was taken as a cut point to determine the significant association between dependent and independent variables.
The prevalence of TB lymphadenitis using GeneXpert, Ziehl–Neelsen staining, and cytology were 138 (47.
4%) (95% CI 41.
70–53.
10), 100 (34.
4%) (95% CI 28.
94–39.
85), and 123 (42.
3%) (95% CI 36.
63–47.
00) respectively.
Nine (3.
1%) participants were infected with rifampicin-resistant gene-positive M.
tuberculosis.
Out of the total M.
tuberculosis detected by GeneXpert (n = 138), 9 (6.
5%) were positive for rifampicin resistance-gene.
Participants with a chronic cough had 2 times odds of developing TB lymphadenitis (AOR: 2.
001, 95% CI 1.
142–3.
508).
Close to half of patients with enlarged lymph nodes were positive for M.
tuberculosis by the GeneXpert method in the study area.
Chronic cough was significantly associated with TB lymphadenitis.
Rifampicin-resistant gene-positive M.
tuberculosis was relatively prevalent among patients with enlarged lymph node in the study area.
Related Results
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant t...
Trends of Mycobacterium Tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern Zone of Tigrai, North Ethiopia
Trends of Mycobacterium Tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern Zone of Tigrai, North Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia
Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends of Mycobacterium Tuberculosis and rifampicin Resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
Trends of Mycobacterium Tuberculosis and rifampicin Resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends in Mycobacterium Tuberculosis and prevalence of Rifampicin Resistance in Eastern zone, Tigray Region, Northern Ethiopia
Trends in Mycobacterium Tuberculosis and prevalence of Rifampicin Resistance in Eastern zone, Tigray Region, Northern Ethiopia
Abstract
Background Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. The emergence of Mono or multidrug-resistant tub...
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea ' s Claim 20/Ethiopia ' s Claim 8, Partial Awards; Economic Loss Throughout Ethiopia (Ethiopia v. Eritrea), Ethiopia ' s Claim 7, Partial Award; Jus ad Bellum (Ethiopia v. Eritrea), Ethiopia ' s Claims 1-8,
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea ' s Claim 20/Ethiopia ' s Claim 8, Partial Awards; Economic Loss Throughout Ethiopia (Ethiopia v. Eritrea), Ethiopia ' s Claim 7, Partial Award; Jus ad Bellum (Ethiopia v. Eritrea), Ethiopia ' s Claims 1-8,
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea's Claim 20/Ethiopia's Claim 8, Partial Awards. At <http://www.pca-cpa.org>.Eritrea Ethiopia Claims Commission, December 19, 2...
Rapid detection of non-rifampicin drug resistant tuberculosis using Xpert MTB/XDR testing: Findings from a multisite drug-resistant tuberculosis case detection surge in Zambia
Rapid detection of non-rifampicin drug resistant tuberculosis using Xpert MTB/XDR testing: Findings from a multisite drug-resistant tuberculosis case detection surge in Zambia
Abstract
Background
Zambia continues to face a high burden of tuberculosis with rising drug resistance, yet diagnosis of non-ri...
Preparation and evaluation of biodegradable rifampicin microparticles using supercritical fluid technique for pulmonary delivery
Preparation and evaluation of biodegradable rifampicin microparticles using supercritical fluid technique for pulmonary delivery
It is of interest to apply a supercritical fluid technology for production of inhalable biodegradable microparticles of rifampicin. The polyhydroxy acids[poly(DL-lactide-co-glvcoli...

